paraquat has been researched along with atorvastatin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khoramjouy, M; Malekinejad, H; Mehrabi, M; Rezaei-Golmisheh, A | 1 |
| Amniattalab, A; Hobbenaghi, R; Khoramjouy, M; Malekinejad, H | 1 |
| Alizadeh-Tabrizi, N; Cheraghi, H; Malekinejad, H; Varasteh, S | 1 |
| Du, J; Meng, X; Wang, J; Wang, R; Xie, H; Zhou, Z; Zhu, Y | 1 |
| Alenabi, A; Hallaj-Salahipour, M; Khoramjouy, M; Malekinejad, H; Malekinejad, M; Masoumi Verki, M | 1 |
| Buendía, JA; Justinico Castro, JA; Sánchez Villamil, JP; Sinisterra, D; Vela, LJT; Zuluaga Salazar, AF | 1 |
6 other study(ies) available for paraquat and atorvastatin
| Article | Year |
|---|---|
Antifibrotic effect of atorvastatin on paraquat-induced pulmonary fibrosis: role of PPARγ receptors.
Topics: Anilides; Animals; Atorvastatin; Body Weight; Heptanoic Acids; Herbicides; Hydroxyproline; Lung; Male; Organ Size; Paraquat; Pioglitazone; PPAR gamma; Protective Agents; Pulmonary Fibrosis; Pyrroles; Rats; Rats, Wistar; RNA, Messenger; Thiazolidinediones; Transforming Growth Factor beta1 | 2013 |
Atorvastatin attenuates the paraquat-induced pulmonary inflammation via PPARγ receptors: a new indication for atorvastatin.
Topics: Animals; Anti-Inflammatory Agents; Atorvastatin; Heptanoic Acids; Herbicides; Interleukin-6; Lung; Male; Malondialdehyde; Nitric Oxide; Paraquat; Peroxidase; Pioglitazone; Pneumonia; PPAR gamma; Pyrroles; Rats, Wistar; Thiazolidinediones; Tumor Necrosis Factor-alpha; Weight Loss | 2014 |
Atorvastatin protected from paraquat-induced cytotoxicity in alveolar macrophages via down-regulation of TLR-4.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Atorvastatin; Cell Survival; Cells, Cultured; Down-Regulation; Herbicides; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Macrophages, Alveolar; Male; Nitric Oxide; Paraquat; Peroxidase; Rats; Toll-Like Receptor 4 | 2017 |
Atorvastatin attenuates paraquat poisoning-induced epithelial-mesenchymal transition via downregulating hypoxia-inducible factor-1 alpha.
Topics: A549 Cells; Animals; Atorvastatin; Cadherins; Cell Line; Epithelial-Mesenchymal Transition; Humans; Hypoxia; Hypoxia-Inducible Factor 1; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Lung Injury; Male; Paraquat; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Signal Transduction; Zonula Occludens-1 Protein | 2018 |
Cardioprotective Effects of Atorvastatin Are Mediated Through PPARγ in Paraquat-Exposed Rats.
Topics: Animals; Antioxidants; Atorvastatin; Cardiotoxicity; Creatine Kinase, MB Form; Cyclooxygenase 2; Disease Models, Animal; Heart Diseases; Lipid Peroxidation; Male; Myocytes, Cardiac; Nitric Oxide; Oxidative Stress; Paraquat; Peroxidase; PPAR gamma; Rats, Wistar; Signal Transduction; Sulfhydryl Compounds | 2019 |
Comparison of four pharmacological strategies aimed to prevent the lung inflammation and paraquat-induced alveolar damage.
Topics: Animals; Antioxidants; Ascorbic Acid; Atorvastatin; Cyclophosphamide; Dexamethasone; Drug Therapy; Drug Therapy, Combination; Heparin; Heparin, Low-Molecular-Weight; Lung; Paraquat; Pneumonia; Pulmonary Alveoli; Pulmonary Fibrosis; Rats, Wistar; Treatment Outcome | 2019 |